MENU
Zentalis Pharmaceuticals (ZNTL) Ownership - Who owns Zentalis Pharmaceuticals?
Profile
Industry
N/A
Address
1359 Broadway
Phone
+1 212 433-3791
Employees
168
Web
https://www.zentalis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
230.03M
P/E Ratio
N/A
Total Cash
36.98M
Projected Growth
N/A
Total Debt
41.32M
Revenue
40.56M
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash/Share
0.52
Total Debt/Equity
N/A
Revenue/Share
0.57 USD as % of share price
Fundamentals
ZNTL
Capitalization
230M
P/E Ratio
N/A
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash
37M
Total Cash/Share
0.52
Total Debt
41.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.57%
Revenue
40.6M
ROE
N/A
Book Value
383M
P/B Ratio
0.60
Cash Flow
N/A
Earnings
-2.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
70K
Current Ratio
6.59
Current Revenue Per Employee
241428.58
Dividends Per Share - Security
N/A
EBITDA
-219.22M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.97
Shares Held By Institutions
604M
Shares Outstanding - Current
71.1M
Total Liabilities
492M
Total Volume MTD
N/A
Value
1
Gain YTD
-78.647
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1359 Broadway
Phone
+1 212 433-3791
Employees
168
Web
https://www.zentalis.com